Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades16
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline
Share Price Information for Astrazeneca (AZN)
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
AstraZeneca Q1 revenues grow, reiterates FY26 constant currency guidance
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that it had delivered solid revenue growth and a series of positive late‑stage trial ...
US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals
* Program aims to reduce trial delays, cut years off drug approval timelines
IN BRIEF: AstraZeneca COPD drug Breztri gets US FDA okay for Asthma
AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Breztri Aerosphere is approved by the US Food & Drug Administration as a maintenance...
AstraZeneca's asthma maintenance treatment receives US FDA approval
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it asthma maintenance treatment Breztri Aerosphere had received approval from the US Foo...
WINNERS & LOSERS: Energy stocks up, Ceres Power extends rally
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.
AstraZeneca says lupus treatment gets US FDA approval
(Alliance News) - AstraZeneca PLC on Monday said its self-administered lupus treatment has been approved in the US.
LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling
(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, w...
AstraZeneca's Saphnelo Pen gets green light from US FDA
(Sharecast News) - Drugmaker AstraZeneca said on Monday that its systemic lupus erythematosus treatment Saphnelo (anifrolumab) hsd received US Food an...
Follow the stocks
